[ad_1] Genomic Health, Inc. (NASDAQ: GHDX) obtained an average "Hold" recommendation from the twelve research firms that cover the company, MarketBeat Ratings reports: Two financial badysts evaluated the title with a sales …
Read More »Genomic Health, Inc. (GHDX) Receives $ 34.22 Consensus From Analysts
